- Serum cytokine analysis
- Inducer: Anti-CD3 monoclonal antibody
- Species: Mouse
Administration of certain biotherapies transiently induces immediate pro-inflammatory cytokine release from T cells. This phenomenon is commonly known as antibody-induced cytokine release syndrome. In extreme cases, it can lead to cytokine storm with serious consequences. In order to mimic the phenomenon, antibody (clone 145-2C11) targeting murine CD3 are commonly administered in mice, and level of serum cytokines, such as interferon gamma (INFg) and interleukin 2 (IL-2) are measured.
At Charles River, we offer the mouse in vivo monoclonal anti-CD3 cytokine release assay to screen effects of immunosuppressive drug candidates.
Figure 1: In vivo anti-CD3 (a-CD3)-induced cytokine release assay for measurement of serum IFN-gamma level at three hours following antibody injection – Dexamethasone (Dex) was administered orally one hour before antibody injection.